Flex-pharma.com

Flex Pharma. Inc. is a biotechnology company that is developing innovative and proprietary treatments for cramps and spasms associated...

What’s new on Flex-pharma.com: Check updates and related news right now. Unfortunately, we cannot detect RSS feed on this website, but you may observe related news or Flex-pharma.com popular pages instead. It is generally safe for browsing, so you may click any item to proceed to the site.

News, stories and media buzz related to Flex Pharma

Subscribe to related news

Proprietary Trading Morning Market Update for Wed., Nov, 4, 2015
via alpha7trading

Proprietary Trading Headlines: Investors punish Volkswagen stock after new ‘irregularities’ – USA TODAY – Investors are punishing Volkswagen after the automaker revealed new “irregularities” in emissions certification of its vehicles. FOREX-Momentum...
Piper Jaffray Thinks Flex Pharma’s Stock is Going to Recover
via analystratings

In a report released today, Joshua Schimmer from Piper Jaffray reiterated an Overweight rating on Flex Pharma (NASDAQ: FLKS), with a price target of $25. The company’s shares opened today at $11.51, close to its 52-week low of $9.23. Schimmer noted...
Flexing muscle: Sidebar: Flex Pharma Inc. Corporate Profile
via biocentury

Flex: Flexing muscle Flex Pharma Inc. Boston, Mass. Technology: TRP ion channel activation Disease focus: Neurology Clinical status: Not disclosed Founded: 2014 by Christoph Westphal, Bruce Bean and Roderick …
Hot Alert: Flex Pharma, Inc. (NASDAQ:FLKS), Industrial Services of America, Inc. (NASDAQ:IDSA), Five9, Inc. (NASDAQ:FIVN...
via kcregister

Flex Pharma, Inc. (NASDAQ:FLKS) announced that the recently completed study in nocturnal leg cramps (NLC) has been selected for late-breaking oral and poster presentations at the American Academy of Neurology (AAN) 68th Annual Meeting being held in Vancouver...
Multiple Sclerosis Pipeline Review Report of 178 Companies
via military-technologies

PUNE, India, July 14, 2016 /PRNewswire/ -- ReportsnReports.com adds "Multiple Sclerosis - Pipeline Review, H1 2016" market research report to its store providing an overview of the Multiple Sclerosis's therapeutic pipeline complete with comparative...

Flex-pharma.com popular pages

Flex Pharma

Novel Treatments for Neuromuscular Disorders Flex Pharma, Inc. is a biotechnology company that is developing innovative and proprietary treatments for cramps and spasms associated with the severe neur...

Flex Pharma

Scientific Co-Founder and Co-Chair SAB; Professor of Neurobiology, Harvard Medical School Flex Pharma scientific co-founder Dr. Bruce Bean is the Robert Winthrop Professor of Neurobiology at Harvard M...